MELISI, DANIELA
 Distribuzione geografica
Continente #
EU - Europa 592
NA - Nord America 545
AS - Asia 74
AF - Africa 21
OC - Oceania 1
Totale 1.233
Nazione #
US - Stati Uniti d'America 531
DE - Germania 175
IT - Italia 171
UA - Ucraina 115
CN - Cina 65
NL - Olanda 47
FI - Finlandia 28
CI - Costa d'Avorio 21
IE - Irlanda 16
SE - Svezia 15
CA - Canada 13
FR - Francia 11
GB - Regno Unito 7
TR - Turchia 7
HU - Ungheria 4
AU - Australia 1
CZ - Repubblica Ceca 1
GR - Grecia 1
MX - Messico 1
PH - Filippine 1
PL - Polonia 1
TW - Taiwan 1
Totale 1.233
Città #
Chandler 165
Jacksonville 58
Amsterdam 46
Millbury 31
Princeton 27
Beijing 23
Naples 23
Boston 17
Nanjing 15
Wilmington 14
Napoli 10
Ottawa 10
Hebei 8
Norwalk 7
Bacoli 6
Ashburn 5
Houston 5
Montescaglioso 5
Nanchang 5
Contrada 4
Kronberg 4
Paris 4
Siena 4
Siracusa 4
Budapest 3
Falls Church 3
Kunming 3
Pomigliano D'arco 3
Potenza 3
Shenyang 3
Varedo 3
Andover 2
Busnago 2
Calgary 2
Caserta 2
Changsha 2
Dearborn 2
Dublin 2
Frankfurt am Main 2
Jiaxing 2
Rende 2
Salerno 2
Salò 2
Stilo 2
Alghero 1
Altavilla Silentina 1
Boardman 1
Bonn 1
Brisbane 1
Castellammare Di Stabia 1
Castelpagano 1
Catanzaro 1
Changchun 1
Fairfield 1
Ferrara 1
Fisciano 1
Giugliano In Campania 1
Guangzhou 1
Hanover 1
Helsinki 1
Kastoria 1
Los Banos 1
Melito di Napoli 1
Monza 1
Mountain View 1
Nocera Superiore 1
Olsztyn 1
Orange 1
Oristano 1
Padova 1
Pozzuoli 1
Redwood City 1
Reggio Calabria 1
Rimini 1
Rome 1
San Antonio 1
San Mateo 1
Shanghai 1
Simi Valley 1
Solofra 1
Stella Cilento 1
Stockholm 1
Tianjin 1
Toronto 1
Urbino 1
Woodbridge 1
Yellow Springs 1
Érd 1
Totale 591
Nome #
2-fenil-imidazo[1,2-B]piridazine ad attività analgesica ed antiepilettica 129
Derivati glicosilati della Nω-Nitro-L-Arginina come agenti antitumorali 100
Profarmaco galattosilato del ketorolac ad uso analgesico e antinfiammatorio con migliori caratteristiche farmacocinetiche e profilo tossicologico del farmaco di partenza 95
Composizioni farmaceutiche a base di zeoliti porose quali mezzi di rilascio di molecole farmacologicamente attive e relativo uso 61
Galactosilated dopamine increases attention without reducing activity in C57BL/6 mice 54
Galactosylated dopamine enters into the brain, blocks mesocorticolimbic system and modulates activity and scanning time in naples high excitability rats 51
D-Galactose as a Vector for Prodrug Design. 51
Synthetic Zeolites as a New Tool for Drug Delivery 49
Galactosyl Derivative of N(omega)-Nitro-L-Arginine: Study of Antiproliferative Activity on Human Thyroid Follicular Carcinoma Cells 49
Pharmaceutical compositions based on porous zeolites as release means of pharmacologically active molecules and relative use 45
Galactosyl derivatives of L-arginine and D-arginine: synthesis, stability, cell permeation, and nitric oxide production in pituitary GH3 cells 43
Profarmaco galattosilato della N-omega-nitro-L-arginina (nagal) ad uso analgesico ed antinfiammatorio con migliore caratteristiche farmacocinetiche e di tollerabilità del farmaco di partenza 43
Principi di analisi quantitativa dei medicinali 42
Intra-periaqueductal grey microinjections of an imidazo[1,2-b]pyridazine derivative, DM2, affects rostral ventromedial medulla cell activity and shows antinociceptive effect 41
Sol-gel processing of anti-inflammatory entrapment in Silica, release kinetics and bioactivity 35
Characterization, bioactivity and ampicillin release kinetics of TiO2 and TiO24SiO2 synthesized by sol-gel processing 33
Molecular pharmacology of the amiloride analog 3-amino-6-chloro-5-[(4-chloro-benzyl)amino]-n-[[(2,4-dimethylbenzyl)-amino]iminomethyl]-pyrazinecarboxamide (CB-DMB) as a pan inhibitor of the Na+-Ca2+ exchanger isoforms NCX1, NCX2, and NCX3 in stably transfected cells 32
Multiple functionalization of fluorescent nanoparticles for specific biolabeling and drug delivery of dopamine. 32
Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations 32
Excitatory amino acids in the forebrain of the Naples high-excitability rats: Neurochemical and behavioural effects of subchronic d-aspartate and its diethyl ester prodrug 31
null 27
Galactosyl prodrug of ketorolac: synthesis, stability, and pharmacological and pharmacokinetic evaluations 27
SEPARAZIONE E ANALISI DELLE PROPRIETA'FARMACOLOGICHE DELLE DIIDROPIRIDINE CHIRALI: VALUTAZIONE COMPARATIVA DEGLI ISOMERI OTTICI DELLA AMLODIPINA E DELLA LERCANIDIPINA. 27
T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacin 22
Glycosyl derivatives of dopamine and L-dopa as anti-Parkinson prodrugs: synthesis, pharmacological activity and in vitro stability studies. 22
Arginine prodrugs with high therapeutic activity 21
null 18
Galactosylated prodrugs of non-steroidal anti-inflammatories with improved pharmacokinetic characteristics and reduced toxicity of the starting drug 18
The galactosylation of N(ω)-nitro-L-arginine enhances its anti-nocifensive or anti-allodynic effects by targeting glia in healthy and neuropathic mice 14
Totale 1.244
Categoria #
all - tutte 3.972
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.972


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 3 3 3
2019/2020117 31 3 10 0 12 0 3 0 4 7 19 28
2020/2021211 9 18 26 17 21 29 25 8 16 3 35 4
2021/2022178 6 3 4 6 3 5 3 4 16 1 62 65
2022/2023346 32 45 8 34 42 34 12 26 51 46 14 2
2023/202493 7 25 21 2 5 5 0 26 0 2 0 0
Totale 1.244